期刊文献+

小鼠CD_8分子α链在SP2/0细胞中的表达及鉴定

Expression and identification of mouse CD_(8α) on SP2/0 cells
暂未订购
导出
摘要 目的构建CD8α真核表达载体,为构建膜型细胞因子提供重要工具。方法采取RT-PCR从磁珠分选的CD8α+T细胞中得到CD8α的cDNA基因,将其克隆入表达载体pVITRO。经测序后转染SP2/0细胞,通过流式细胞仪和激光共聚焦显微镜检测CD8α分子在SP2/0细胞中的表达情况。结果构建的pVITRO/CD8α载体测序后,Genebank比对证实为CD8α的cD-NA分子,流式细胞仪和激光共聚焦显微镜结果均说明CD8α在SP2/0细胞的细胞膜上得到表达。结论 CD8α在真核细胞膜上能成功表达,为进一步构建膜表达型细胞因子奠定了基础。 Objective To provide an experimental tool to construct membrane-bound form of cytokines,the mouse CD8α were inserted into expressing vector pVITRO.Methods Mouse CD8α+ T cells were enriched by using CD8α-conjugated microbeads.The total RNA from CD8α+ T cells were isolated at first,Then RT-PCR were used by oligodT primer and CD8α pair primers respectively.cDNA sequences were cloned into expressing vector pVITRO.After sequencing,the recombinant plasmid pVITRO/CD8α was transfected into SP2/0 cells with liposome.The expression of CD8α on SP2/0 cells was detected by flow cytometery and confocal microscopy.Results The results of sequencing and blasting in the genebank show that we have got a cDNA sequence of CD8α.CD8α expression on SP2/0 cell surface was confirmed by flow cytometery and confocal microscopy.Conclusions CD8α was expressed on SP2/0 cell surface,which laid a solid foundation for constructing the membrane-bound form of cytokines by genetic engineering techniques in future.
机构地区 扬州大学医学院
出处 《实用临床医药杂志》 CAS 2011年第1期1-3,14,共4页 Journal of Clinical Medicine in Practice
基金 国家自然科学基金资助项目(81001308) 江苏省自然科学基金资助项目(BK2010315) 扬州大学高层次人才科研启动基金资助项目
关键词 CD8Α SP2/0细胞 表达 CD8α SP2/0 cells expression
  • 相关文献

参考文献10

  • 1Kim Y S.Tumor therapy applying membrane-bound form of cytokines[J].Imme netw,2009,9:158.
  • 2Musso T,Calosso L,Zucca M,et al.Human monocytes constitutively expressmembranebound,biologically active,and interferon-gamma up-regulated interleukin-15[J].Blood,1999,93:3531.
  • 3Kobayashi H,Dubois S,Sato N,et al.The role of trans-cellular IL-15-presentation in the activation of NK-mediated killing,which leads to enhanced tumor immune surveillance[J].Blood,2005,105:721.
  • 4Imai C,Iwamoto S,Campana D.Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells[J].Blood,2005,106:376.
  • 5Kim Y S,Sonn C H,Paik S G,et al.Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity[J].Gene Ther,2000,7:837.
  • 6Taieb J,Chaput N,Menard C,et al.A novel dendritic cell subset involved in tumor immunosurveillance[J].Nat Med,2006,12:214.
  • 7Chan C W,Crafton E,Fan H N,et al.Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity[J].Nat Med,2006,12:207.
  • 8Ullrich E,Ménard C,Flament C,et al.Dendritic cells and innate defense against tumor cells[J].Cytokine Growth Factor Rev,2008,19:79.
  • 9Himoudi N,Nabarro S,Buddle J,et al.Bone marrow-derived IFN-producing killer dendritic cells account for the tumoricidal activity of unpulsed dendritic cells.J Immunol[J].2008,181:6654.
  • 10Mignot G,Ullrich E,Bonmort M,et al.The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2[J].J Immunol,2008,180:6477.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部